Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ACHC
stocks logo

ACHC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
801.84M
+3.57%
0.410
-35.94%
817.16M
+6.05%
0.388
-2.93%
887.46M
+2.1%
0.733
-11.67%
Estimates Revision
The market is revising Downward the revenue expectations for Acadia Healthcare Company, Inc. (ACHC) for FY2025, with the revenue forecasts being adjusted by -0.83% over the past three months. During the same period, the stock price has changed by -38.28%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.83%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-6.95%
In Past 3 Month
Stock Price
Go Down
down Image
-38.28%
In Past 3 Month
Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 25.56 USD with a low forecast of 17.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 25.56 USD with a low forecast of 17.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 14.640
sliders
Low
17.00
Averages
25.56
High
30.00
Current: 14.640
sliders
Low
17.00
Averages
25.56
High
30.00
Barclays
Andrew Mok
Equal Weight
downgrade
$17 -> $14
2025-12-04
New
Reason
Barclays
Andrew Mok
Price Target
$17 -> $14
2025-12-04
New
downgrade
Equal Weight
Reason
Barclays analyst Andrew Mok lowered the firm's price target on Acadia Healthcare to $14 from $17 and keeps an Equal Weight rating on the shares. The company cut its guidance for the third time this year due to an unexpected $49M increase in legal expenses, the analyst tells investors in a research note.
UBS
AJ Rice
Buy
downgrade
$28 -> $24
2025-12-03
New
Reason
UBS
AJ Rice
Price Target
$28 -> $24
2025-12-03
New
downgrade
Buy
Reason
UBS analyst AJ Rice lowered the firm's price target on Acadia Healthcare to $24 from $28 and keeps a Buy rating on the shares. Acadia lowered its 2025 guidance due to a $50M liability reserve accrual expected in Q4, the analyst tells investors in a research note.
Cantor Fitzgerald
Neutral
downgrade
$22 -> $17
2025-12-03
New
Reason
Cantor Fitzgerald
Price Target
$22 -> $17
2025-12-03
New
downgrade
Neutral
Reason
Cantor Fitzgerald lowered the firm's price target on Acadia Healthcare to $17 from $22 and keeps a Neutral rating on the shares. Acadia cut its 2025 EBITDA guidance by $49M to $601-611M, marking a total $94M reduction since the initial forecast, primarily due to professional and general liability expenses, the analyst tells investors in a research note. With limited near-term recovery catalysts and modest 2026 PLGL tailwinds of $6-16M, the outlook remains cautious, the firm says.
RBC Capital
Outperform
downgrade
$22 -> $19
2025-12-03
New
Reason
RBC Capital
Price Target
$22 -> $19
2025-12-03
New
downgrade
Outperform
Reason
RBC Capital lowered the firm's price target on Acadia Healthcare to $19 from $22 and keeps an Outperform rating on the shares. The firm cites the company having disappointed with yet another downward guidance revision as Acadia underestimated its expected 2025 PLGL - professional and general liability - expenses, the analyst tells investors in a research note, adding that the management also expects liability expenses to remain elevated through 2026.
Deutsche Bank
Pito Chickering
Buy
downgrade
$33 -> $20
2025-12-03
New
Reason
Deutsche Bank
Pito Chickering
Price Target
$33 -> $20
2025-12-03
New
downgrade
Buy
Reason
Deutsche Bank analyst Pito Chickering lowered the firm's price target on Acadia Healthcare to $20 from $33 and keeps a Buy rating on the shares. The company in a regulatory filing reduced its 2025 EBITDA guidance by 7.5% due to a $49M increase in its expectations for 2025 professional and general liability reserves expense, the analyst tells investors in a research note.
BofA
Joanna Gajuk
Neutral -> Underperform
downgrade
$13
2025-12-03
New
Reason
BofA
Joanna Gajuk
Price Target
$13
2025-12-03
New
downgrade
Neutral -> Underperform
Reason
BofA analyst Joanna Gajuk downgraded Acadia Healthcare to Underperform from Neutral with a price target of $13, down from $21.50.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Acadia Healthcare Company Inc (ACHC.O) is 8.44, compared to its 5-year average forward P/E of 19.25. For a more detailed relative valuation and DCF analysis to assess Acadia Healthcare Company Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PE
19.25
Current PE
8.44
Overvalued PE
24.41
Undervalued PE
14.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
11.29
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
13.89
Undervalued EV/EBITDA
8.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.94
Current PS
0.00
Overvalued PS
2.61
Undervalued PS
1.28
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 194.77% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

ACHC News & Events

Events Timeline

(ET)
2025-12-02
21:30:00
U.S. Indices Pause Gains but Risk-On Sentiment Returns
select
2025-12-02
19:20:00
U.S. Indices Pause but Rally Resumes; Boeing Shares Surge 10%
select
link
2025-12-02
17:10:00
Acadia Healthcare Cuts FY25 Guidance, Stock Drops 24%
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
12-04Businesswire
Acadia Healthcare Company Lowers 2025 EBITDA Guidance to $611 Million Amid Litigation Costs
  • EBITDA Guidance Cut: Acadia Healthcare Company now expects its 2025 adjusted EBITDA to range between $601 million and $611 million, significantly down from the previous guidance of $650 million to $660 million, indicating rising legal costs that could negatively impact investor confidence.
  • Surge in Litigation Costs: The company projects its 2025 PLGL expenses to reach approximately $116 million, up $62 million from $54 million in 2024, primarily due to increased claim frequency and less favorable reinsurance terms, highlighting escalating legal risks.
  • Stock Price Plunge: Following this announcement, Acadia's stock price fell by $1.80, or 10.9%, closing at $14.69 on December 3, 2025, directly affecting the value of investors' holdings.
  • Legal Investigation Launched: The Law Offices of Howard G. Smith have initiated an investigation into Acadia, aiming to provide legal support for affected investors, reflecting heightened market concerns regarding the company's compliance and financial transparency.
[object Object]
Preview
7.0
12-04Newsfilter
Acadia Healthcare Faces Securities Law Investigation, 2025 EBITDA Guidance Cut
  • Legal Investigation Initiated: The Law Offices of Howard G. Smith announced an investigation into Acadia Healthcare for potential violations of federal securities laws, which may lead to significant losses for investors.
  • Financial Guidance Cut: Acadia now expects its 2025 Adjusted EBITDA to be between $601 million and $611 million, down from the previous guidance of $650 million to $660 million, indicating increased financial pressures due to higher patient-related litigation costs.
  • Surge in Litigation Costs: The company projects 2025 PLGL expenses to be approximately $116 million, a $62 million increase from $54 million in 2024, primarily due to rising claim frequency and less favorable reinsurance terms, which could jeopardize financial stability.
  • Significant Stock Price Drop: On December 3, 2025, Acadia's stock fell by $1.80, or 10.9%, closing at $14.69, reflecting market concerns about the company's outlook and potentially diminishing investor confidence.
[object Object]
Preview
4.5
12-04NASDAQ.COM
Stocks Rise on Hope for Fed Rate Cuts

  • Market Performance: The S&P 500, Dow Jones, and Nasdaq 100 all closed higher on Wednesday, with the S&P 500 and Nasdaq reaching three-week highs, supported by a weaker-than-expected ADP employment report that lowered bond yields and increased expectations for a Fed interest rate cut.

  • Sector Highlights: Chipmakers saw significant gains, with Microchip Technology rising over 12% after a strong earnings forecast, while other tech stocks also performed well. Conversely, concerns over AI demand affected Microsoft, which saw a decline in stock price.

  • Economic Indicators: The November ADP employment report indicated an unexpected job loss of 32,000, the largest drop in over 2.5 years, while the ISM services index showed unexpected growth, suggesting mixed signals in the labor market and economic activity.

  • Upcoming Economic Focus: Market attention is on upcoming economic reports, including unemployment claims and personal spending, with a high probability of a 25 basis point rate cut anticipated at the next FOMC meeting on December 9-10.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Acadia Healthcare Company Inc (ACHC) stock price today?

The current price of ACHC is 14.64 USD — it has decreased -0.34 % in the last trading day.

arrow icon

What is Acadia Healthcare Company Inc (ACHC)'s business?

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its comprehensive treatment centers specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. It operates a network of 262 behavioral healthcare facilities with over 11,850 beds in 39 states and Puerto Rico.

arrow icon

What is the price predicton of ACHC Stock?

Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 25.56 USD with a low forecast of 17.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Acadia Healthcare Company Inc (ACHC)'s revenue for the last quarter?

Acadia Healthcare Company Inc revenue for the last quarter amounts to 851.57M USD, increased 4.41 % YoY.

arrow icon

What is Acadia Healthcare Company Inc (ACHC)'s earnings per share (EPS) for the last quarter?

Acadia Healthcare Company Inc. EPS for the last quarter amounts to 0.40 USD, decreased -45.95 % YoY.

arrow icon

What changes have occurred in the market's expectations for Acadia Healthcare Company Inc (ACHC)'s fundamentals?

The market is revising Downward the revenue expectations for Acadia Healthcare Company, Inc. (ACHC) for FY2025, with the revenue forecasts being adjusted by -0.83% over the past three months. During the same period, the stock price has changed by -38.28%.
arrow icon

How many employees does Acadia Healthcare Company Inc (ACHC). have?

Acadia Healthcare Company Inc (ACHC) has 19192 emplpoyees as of December 05 2025.

arrow icon

What is Acadia Healthcare Company Inc (ACHC) market cap?

Today ACHC has the market capitalization of 1.35B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free